NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE

Clinical trials for NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE explained in plain language.

Never miss a new study

Get alerted when new NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE trials appear

Sign up with your email to follow new studies for NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for kids with rare kidney disease

Disease control Not yet recruiting

This study is testing an investigational drug called atrasentan in children and teenagers (ages 2 to 18) who have a kidney disease called IgA nephropathy. The main goal is to see if the drug safely reduces the amount of protein in the urine, which is a key sign of kidney damage. …

Matched conditions: NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 03, 2026 14:48 UTC

NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE

Get alerted when new NEPHRITIS IGA TYPE, NEPHROPATHY IGA TYPE trials appear

New hope for kids with rare kidney disease